245 related articles for article (PubMed ID: 33522579)
1. Neurokinin 3 Receptor Antagonism Ameliorates Key Metabolic Features in a Hyperandrogenic PCOS Mouse Model.
Sucquart IE; Nagarkar R; Edwards MC; Rodriguez Paris V; Aflatounian A; Bertoldo MJ; Campbell RE; Gilchrist RB; Begg DP; Handelsman DJ; Padmanabhan V; Anderson RA; Walters KA
Endocrinology; 2021 May; 162(5):. PubMed ID: 33522579
[TBL] [Abstract][Full Text] [Related]
2. Androgen signaling in adipose tissue, but less likely skeletal muscle, mediates development of metabolic traits in a PCOS mouse model.
Xiong T; Rodriguez Paris V; Edwards MC; Hu Y; Cochran BJ; Rye KA; Ledger WL; Padmanabhan V; Handelsman DJ; Gilchrist RB; Walters KA
Am J Physiol Endocrinol Metab; 2022 Aug; 323(2):E145-E158. PubMed ID: 35658542
[TBL] [Abstract][Full Text] [Related]
3. Androgen Action in Adipose Tissue and the Brain are Key Mediators in the Development of PCOS Traits in a Mouse Model.
Cox MJ; Edwards MC; Rodriguez Paris V; Aflatounian A; Ledger WL; Gilchrist RB; Padmanabhan V; Handelsman DJ; Walters KA
Endocrinology; 2020 Jul; 161(7):. PubMed ID: 32301482
[TBL] [Abstract][Full Text] [Related]
4. The overexpression of neurokinin B-neurokinin 3 receptor system exerts direct effects on the ovary under PCOS-like conditions to interfere with mitochondrial function.
Guo F; Fernando T; Zhu X; Shi Y
Am J Reprod Immunol; 2023 Mar; 89(3):e13663. PubMed ID: 36453600
[TBL] [Abstract][Full Text] [Related]
5. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models.
Caldwell AS; Middleton LJ; Jimenez M; Desai R; McMahon AC; Allan CM; Handelsman DJ; Walters KA
Endocrinology; 2014 Aug; 155(8):3146-59. PubMed ID: 24877633
[TBL] [Abstract][Full Text] [Related]
6. Androgen signaling pathways driving reproductive and metabolic phenotypes in a PCOS mouse model.
Aflatounian A; Edwards MC; Rodriguez Paris V; Bertoldo MJ; Desai R; Gilchrist RB; Ledger WL; Handelsman DJ; Walters KA
J Endocrinol; 2020 Jun; 245(3):381-395. PubMed ID: 32229702
[TBL] [Abstract][Full Text] [Related]
7. Haplosufficient genomic androgen receptor signaling is adequate to protect female mice from induction of polycystic ovary syndrome features by prenatal hyperandrogenization.
Caldwell AS; Eid S; Kay CR; Jimenez M; McMahon AC; Desai R; Allan CM; Smith JT; Handelsman DJ; Walters KA
Endocrinology; 2015 Apr; 156(4):1441-52. PubMed ID: 25643156
[TBL] [Abstract][Full Text] [Related]
8. Neurokinin 3 receptor antagonist-induced adipocyte activation improves obesity and metabolism in PCOS-like mice.
Zhang L; Fernando T; Liu Y; Liu Y; Zhu X; Li M; Shi Y
Life Sci; 2022 Dec; 310():121078. PubMed ID: 36252700
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of the kisspeptin/KISS1R and neurokinin B/NK3R systems in mural granulosa and cumulus cells of patients with polycystic ovarian syndrome.
Blasco V; Pinto FM; Fernández-Atucha A; Prados N; Tena-Sempere M; Fernández-Sánchez M; Candenas L
J Assist Reprod Genet; 2019 Jan; 36(1):113-120. PubMed ID: 30382469
[TBL] [Abstract][Full Text] [Related]
10. Deletion of Androgen Receptors From Kisspeptin Neurons Prevents PCOS Features in a Letrozole Mouse Model.
Decourt C; Watanabe Y; Evans MC; Inglis MA; Fisher LC; Jasoni CL; Campbell RE; Anderson GM
Endocrinology; 2023 Apr; 164(6):. PubMed ID: 37191144
[TBL] [Abstract][Full Text] [Related]
11. Investigating GABA Neuron-Specific Androgen Receptor Knockout in two Hyperandrogenic Models of PCOS.
Sucquart IE; Coyle C; Rodriguez Paris V; Prescott M; Glendining KA; Potapov K; Begg DP; Gilchrist RB; Walters KA; Campbell RE
Endocrinology; 2024 May; 165(7):. PubMed ID: 38788194
[TBL] [Abstract][Full Text] [Related]
12. Removal of DHT can relieve polycystic ovarian but not metabolic abnormalities in DHT-induced hyperandrogenism in mice.
Sun LF; Yang YL; Xiao TX; Li MX; Zhang JV
Reprod Fertil Dev; 2019 Sep; 31(10):1597-1606. PubMed ID: 31142430
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome.
Caldwell ASL; Edwards MC; Desai R; Jimenez M; Gilchrist RB; Handelsman DJ; Walters KA
Proc Natl Acad Sci U S A; 2017 Apr; 114(16):E3334-E3343. PubMed ID: 28320971
[TBL] [Abstract][Full Text] [Related]
14. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
15. Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology.
Krishnan A; Muthusami S; Periyasamy L; Stanley JA; Gopalakrishnan V; Ramachandran I
Medicina (Kaunas); 2020 Feb; 56(3):. PubMed ID: 32120970
[No Abstract] [Full Text] [Related]
16. The polycystic ovary syndrome-associated gene Yap1 is regulated by gonadotropins and sex steroid hormones in hyperandrogenism-induced oligo-ovulation in mouse.
Ji SY; Liu XM; Li BT; Zhang YL; Liu HB; Zhang YC; Chen ZJ; Liu J; Fan HY
Mol Hum Reprod; 2017 Oct; 23(10):698-707. PubMed ID: 28961951
[TBL] [Abstract][Full Text] [Related]
17. Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS).
Garg A; Patel B; Abbara A; Dhillo WS
Clin Endocrinol (Oxf); 2022 Aug; 97(2):156-164. PubMed ID: 35262967
[TBL] [Abstract][Full Text] [Related]
18. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME--PART 1.
Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
Endocr Pract; 2015 Nov; 21(11):1291-300. PubMed ID: 26509855
[TBL] [Abstract][Full Text] [Related]
19. Reproductive and metabolic phenotype of a mouse model of PCOS.
van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
[TBL] [Abstract][Full Text] [Related]
20. Pathogenesis of Reproductive and Metabolic PCOS Traits in a Mouse Model.
Rodriguez Paris V; Edwards MC; Aflatounian A; Bertoldo MJ; Ledger WL; Handelsman DJ; Gilchrist RB; Walters KA
J Endocr Soc; 2021 Jun; 5(6):bvab060. PubMed ID: 34056500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
